Super V3 Investment Limited Partnership Jafco, 10% Owner at Tracon Pharmaceuticals, Inc. (TCON), sold 42,344 shares at $11.76 ($499K) on 2015-09-17, disclosed to the SEC on 2015-09-17.
Open-market sale of $499k TCON by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.79 | 17,300 | $204K | 40.9% |
| 2 | $11.84 | 5,552 | $66K | 13.2% |
| 3 | $11.76 | 19,492 | $229K | 45.9% |
| Total | $11.78 avg | 42,344 | $499K | 100% |
| Filing → |
| TCON | SELL | 2015-10-13 | $32K | — | Filing → |
| TCON | SELL | 2015-10-08 | $221K | — | Filing → |
| TCON | SELL | 2015-10-06 | $152K | — | Filing → |